Evidence map›Paper›PMID 41552356›Full record

ArticleHealth policy OPEN2026

Cross-sectional analysis of accuracy versus interpretability in Medicare Advantage risk adjustment.

Maya Lozinski

Abstract read
In one paragraph

Article in Health policy OPEN, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Maya LozinskiDepartment of Medicine, Massachusetts General Hospital, USA.

Funding

The Institute for Translational MedicineUL1TR002389 · NCATS · UNIVERSITY OF CHICAGO · PI Joshua J Jacobs, DAVID O MELTZER · 2017 to 2026
$71.6M
MEDICAL SCIENTIST TRAININGT32GM007281 · NIGMS · UNIVERSITY OF CHICAGO · PI CLARK, MARCUS RAMSAY · 1985 to 2022
$32.1M
MD/PhD Program in Medicine, the Social Sciences and AgingT32AG051146 · NIA · UNIVERSITY OF CHICAGO · PI MELTZER, DAVID O · 2015 to 2019
$1.0M
AHRQ HHS R36 HS028592NCATS NIH HHS UL1 TR002389NIA NIH HHS T32 AG051146NIGMS NIH HHS T32 GM007281
6 · The paper itself

Abstract

Background: Risk adjustment models in Medicare Advantage determine annual payments of over $300 billion in public funds to private companies. Policymakers want risk adjustment models that are both accurate and interpretable to ensure appropriate use of public funds. Methods: The trade-off between accuracy and interpretability from using standard machine learning (ML) models for risk adjustment was evaluated. A cross-sectional analysis was conducted using 2018-2019 Medicare claims with 3,602,618 beneficiaries. Multiple risk adjustment models were estimated, including traditional and ML-based approaches. Performance was assessed using out-of-sample mean absolute and squared error (MAE and MSE). Interpretability was measured using coefficient count and log-transformed coefficient count of models. Results: ML models, especially gradient-boosted trees, significantly improved prediction accuracy relative to recent Medicare models, with MAE reductions of - 1,352 (95 % CI: -1,392, -1,316) and MSE reductions of - 5 (95 % CI: -9, -1). However, these improvements increased model complexity by more than 1000x and provided less than 0.1 % of the accuracy improvement per additional coefficient of a previous major model change. Notably, the predictions from gradient-boosted trees responded less to strategic diagnosis coding, reducing incentives to upcode. Conclusions: Standard ML models can modestly improve predictive accuracy but substantially worsen model interpretability in risk adjustment. Future research is needed to improve accuracy in these models while maintaining the interpretability essential for oversight of public spending.

Indexed as

AccuracyComplexityMedicare risk adjustmentTabular machine learningUpcoding incentives

Identifiers

PMID41552356
PMCPMC12811633

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.